ETF · holdings as filed 2026-03-31
What's inside XPH?
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
Holdings
60
positions in the fund
Expense ratio
0.35%
net, per year
Fund size
$308M
total net assets
Top 15 holdings
1
GVMXXSTATE ST INST US GOV MM-PREM
8.01%
2
ELVNENLIVEN THERAPEUTICS INC
2.45%
3
CORTCORCEPT THERAPEUTICS INC
2.29%
4
430TERNS PHARMACEUTICALS INC
2.16%
6
AXSMAXSOME THERAPEUTICS INC
2.03%
8
MRKMERCK & CO. INC.
1.98%
10
RPRXROYALTY PHARMA PLC- CL A
1.97%
11
ELANELANCO ANIMAL HEALTH INC
1.96%
12
JAZZJAZZ PHARMACEUTICALS PLC
1.96%
13
ESPRESPERION THERAPEUTICS INC
1.95%
14
EWTXEDGEWISE THERAPEUTICS INC
1.95%
15
MBXMBX BIOSCIENCES INC
1.95%
Hold XPH alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Data source: official SEC Form N-PORT filings (as of 2026-03-31); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.